GlassScriptPhysician profile
Leslie Jackson
NPI 1144906355
$1,007.88
in general payments reported to CMS, 2019-2025
18 companies · $533 in 2025
The $533 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $127 · 2024: $348 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.59 | 2024-2025 | |
| Amgen INC. | $140.28 | 2023-2024 | Repatha, Otezla |
| Corcept Therapeutics | $70.78 | 2025 | Korlym |
| Lilly USA, LLC | $68.11 | 2024 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $61.26 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.16 | 2024-2025 | Jardiance |
| Lundbeck LLC | $32.07 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.95 | 2025 | Xifaxan |
| Dexcom, INC. | $22.92 | 2025 | Dexcom G6 Transmitter |
| Kedrion Biopharma, INC. | $20.39 | 2025 | Kedrab, Gammaked, Koate |
| Glaxosmithkline, LLC. | $20.10 | 2024 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $18.72 | 2025 | Spravato |
| Exact Sciences Corporation | $16.95 | 2025 | The Cologuard Plus Collection Kit |
| Organon LLC | $15.24 | 2025 | Nexplanon |
| Vertex Pharmaceuticals Incorporated | $15.03 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.57 | 2025 | Veozah |
| Novo Nordisk INC | $14.53 | 2024 | Wegovy |
| Phathom Pharmaceuticals, INC. | $13.23 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.